-
1.发明授权公开(公告)号：US08808219B2
公开(公告)日：2014-08-19
申请号：US12366242
申请日：2009-02-05
申请人： Olav B Bergheim , Morteza Gharib
发明人： Olav B Bergheim , Morteza Gharib
CPC分类号： A61F9/00781 , A61F9/0017 , A61F9/007 , A61F2009/00891 , A61F2250/0067 , A61K9/0051 , A61M27/002 , A61M2210/0612 , Y10S623/905
摘要： Implants and methods for treating ocular disorders are described. One method involves providing an elongated delivery device and an implant mounted at a distal end of the delivery device. An incision is formed in eye tissue and the implant is inserted the through the incision using the delivery device. The implant is implanted at a location communicating with a physiologic outflow pathway of an eye such that a distal end portion of the implant and a proximal end portion of the delivery device are relatively disposed in a non-linear orientation during implantation. In one method, the implant is non-linear after insertion.
摘要翻译： 描述了用于治疗眼部疾病的植入物和方法。 一种方法包括提供细长的输送装置和安装在输送装置的远端处的植入物。 在眼组织中形成切口，并且使用输送装置将植入物插入穿过切口。 将植入物植入在与眼睛的生理流出道相通的位置处，使得植入物的远端部分和输送装置的近端部分在植入期间以非线性取向相对地布置。 在一种方法中，植入物在插入后是非线性的。
-
公开(公告)号：US08801648B2
公开(公告)日：2014-08-12
申请号：US12366565
申请日：2009-02-05
申请人： Olav B Bergheim , Morteza Gharib
发明人： Olav B Bergheim , Morteza Gharib
CPC分类号： A61F9/00781 , A61F9/0017 , A61F9/007 , A61F2009/00891 , A61F2250/0067 , A61K9/0051 , A61M27/002 , A61M2210/0612 , Y10S623/905
摘要： Implants and methods for treating ocular disorders are disclosed. One implant has an inlet portion configured to extend through a portion of a tissue of an eye and an outlet portion configured to extend into and along a physiologic outflow pathway of the eye. The implant provides a flow path between an anterior chamber of the eye and the physiologic outflow pathway. One implant includes a body having adjacent regions of differing cross-sectional dimensions configured to anchor the implant and/or stabilize at least a portion of the flow path through the implant. One method involves inserting a fiber optic in an eye, locating a distal end of the fiber optic at a physiologic outflow pathway through which aqueous humor drains from an anterior chamber of the eye, and delivering a material comprising a therapeutic agent along the fiber optic and into the physiologic outflow pathway.
摘要翻译： 公开了用于治疗眼部疾病的植入物和方法。 一个植入物具有被配置为延伸穿过眼睛的组织的一部分的入口部分和被配置为延伸到眼睛的生理流出道中并沿着眼睛的生理流出路径的出口部分。 植入物提供眼睛前房和生理流出路径之间的流动路径。 一个植入物包括具有不同横截面尺寸的相邻区域的主体，其被构造成锚定植入物和/或稳定通过植入物的流动路径的至少一部分。 一种方法是将光纤插入到眼睛中，将光纤的远端定位在生理学流出路径，通过该生理流出路径，房水从眼睛的前房排出，以及沿着光纤传送包含治疗剂的材料， 进入生理流出途径。
-
公开(公告)号：US08348877B2
公开(公告)日：2013-01-08
申请号：US12772889
申请日：2010-05-03
申请人： Hosheng Tu , Barbara Niksch , David Haffner , Gregory Smedley , Olav B Bergheim , Morteza Gharib
发明人： Hosheng Tu , Barbara Niksch , David Haffner , Gregory Smedley , Olav B Bergheim , Morteza Gharib
IPC分类号： A61M19/00
CPC分类号： A61F9/00781 , A61F9/0017 , A61F2250/0067 , A61L27/54 , A61L2300/258 , A61L2300/41 , A61L2300/414 , A61L2300/416 , A61L2300/42 , A61L2430/16 , A61M27/002
摘要： Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye such that at least a distal end of the implant is temporarily in the anterior chamber. The implant is implanted into eye tissue adjacent the anterior chamber. A therapeutic agent is eluted from the implant into at least one of the anterior chamber, a physiologic outflow pathway of the eye, and a space adjacent a choroid of the eye. The therapeutic agent can be an antiproliferative agent, an anti-inflammatory drug, or a compound for treating glaucoma or ocular hypertension. The therapeutic agent can be contained within the implant or coated on the implant.
摘要翻译： 提供了用于治疗眼部疾病的植入物和方法。 一种方法包括将植入物引入眼睛的前房，使得植入物的至少远端暂时位于前房中。 将植入物植入邻近前房的眼组织。 将治疗剂从植入物洗脱到前房中的至少一个，眼睛的生理流出路径和与眼睛的脉络膜相邻的空间。 治疗剂可以是抗增生剂，抗炎药或治疗青光眼或高眼压症的化合物。 治疗剂可以包含在植入物内或涂覆在植入物上。
-
-
搜索结果
3 条记录 (耗时 0.018 秒)
